PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

clindamycin Side Effects

The reactions most often reported to the FDA for clindamycin (also sold as Cleocin), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

27,449
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 1999 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of clindamycin come from 27,449 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 27,449 reports to the FDA Adverse Event Reporting System (FAERS) for clindamycin (Cleocin): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

27,449

Reports Mentioning Death

2,286

8.3% of reports — not proof the medicine caused the death

Hospitalizations

10,349

37.7% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

DRUG HYPERSENSITIVITY
2,314
DIARRHOEA
1,878
RASH
1,622
NAUSEA
1,616
PAIN
1,505
ACUTE KIDNEY INJURY
1,310
CHRONIC KIDNEY DISEASE
1,298
FATIGUE
1,261
DYSPNOEA
1,179
PYREXIA
1,168
RENAL FAILURE
1,072
VOMITING
981
HEADACHE
953
PRURITUS
917
ANXIETY
849
ARTHRALGIA
837
CONDITION AGGRAVATED
823
DIZZINESS
727

Who Reports Side Effects

Gender Distribution

Female 15,625 (62%)
Male 9,703 (38%)
Unknown 61

Age Distribution

0-17 1,594 (8%)
18-44 4,819 (26%)
45-64 6,698 (36%)
65-74 3,150 (17%)
75+ 2,553 (14%)

Reporting Trend by Year

1999 2025

Reactions in Death Reports

Top reactions reported in 2,286 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 487
RENAL FAILURE 209
SEPSIS 178
SEPTIC SHOCK 165
ACUTE KIDNEY INJURY 164
PNEUMONIA 158
MULTIPLE ORGAN DYSFUNCTION SYNDROME 157
CHRONIC KIDNEY DISEASE 140
RESPIRATORY FAILURE 129
PAIN 128
PYREXIA 115
DYSPNOEA 109
CONDITION AGGRAVATED 103
CARDIAC ARREST 101
HYPOTENSION 95
ANAEMIA 94
NAUSEA 94
FATIGUE 86

Reactions in Hospitalization Reports

Top reactions in 10,349 reports where hospitalization was an outcome.

Reaction Reports
DIARRHOEA 808
PYREXIA 756
NAUSEA 745
ACUTE KIDNEY INJURY 705
PAIN 692
DYSPNOEA 657
RASH 550
VOMITING 548
FATIGUE 516
PNEUMONIA 461
RENAL FAILURE 454
HEADACHE 405
CELLULITIS 391
ASTHENIA 387
ANAEMIA 372
CONDITION AGGRAVATED 368
FALL 368
HYPOTENSION 361

Compare clindamycin vs amikacin →

What the FAERS Data Reveals About clindamycin Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 27,449 voluntary reports linked to clindamycin and its brand equivalents (Cleocin), spanning 1999 through 2025. Of those, 2,286 (8.3%) listed death as an outcome and 10,349 (37.7%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 62% were female and 38% male; age distribution skews toward 45-64, with 6,698 reports in that bracket. The single most reported reaction is drug hypersensitivity with 2,314 submissions, followed by diarrhoea and rash.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.